305 related articles for article (PubMed ID: 11473067)
1. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group.
Danne T; Mortensen HB; Hougaard P; Lynggaard H; Aanstoot HJ; Chiarelli F; Daneman D; Dorchy H; Garandeau P; Greene SA; Hoey H; Holl RW; Kaprio EA; Kocova M; Martul P; Matsuura N; Robertson KJ; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J;
Diabetes Care; 2001 Aug; 24(8):1342-7. PubMed ID: 11473067
[TBL] [Abstract][Full Text] [Related]
2. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
Craig ME; Jones TW; Silink M; Ping YJ
J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
[TBL] [Abstract][Full Text] [Related]
3. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes.
Mortensen HB; Hougaard P
Diabetes Care; 1997 May; 20(5):714-20. PubMed ID: 9135932
[TBL] [Abstract][Full Text] [Related]
4. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
[TBL] [Abstract][Full Text] [Related]
5. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
Willi SM; Planton J; Egede L; Schwarz S
J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
[TBL] [Abstract][Full Text] [Related]
6. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
[TBL] [Abstract][Full Text] [Related]
7. Effect of automated bio-behavioral feedback on the control of type 1 diabetes.
Kovatchev BP; Mendosa P; Anderson S; Hawley JS; Ritterband LM; Gonder-Frederick L
Diabetes Care; 2011 Feb; 34(2):302-7. PubMed ID: 21216860
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
9. Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria.
Rosenbauer J; Dost A; Karges B; Hungele A; Stahl A; Bächle C; Gerstl EM; Kastendieck C; Hofer SE; Holl RW;
Diabetes Care; 2012 Jan; 35(1):80-6. PubMed ID: 22074726
[TBL] [Abstract][Full Text] [Related]
10. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study.
Hartemann-Heurtier A; Sachon C; Masseboeuf N; Corset E; Grimaldi A
Diabetes Metab; 2003 Feb; 29(1):53-7. PubMed ID: 12629448
[TBL] [Abstract][Full Text] [Related]
11. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.
Maniatis AK; Klingensmith GJ; Slover RH; Mowry CJ; Chase HP
Pediatrics; 2001 Feb; 107(2):351-6. PubMed ID: 11158469
[TBL] [Abstract][Full Text] [Related]
13. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).
Schaepelynck-Bélicar P; Vague P; Simonin G; Lassmann-Vague V
Diabetes Metab; 2003 Dec; 29(6):608-12. PubMed ID: 14707890
[TBL] [Abstract][Full Text] [Related]
14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
15. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
Downie E; Craig ME; Hing S; Cusumano J; Chan AK; Donaghue KC
Diabetes Care; 2011 Nov; 34(11):2368-73. PubMed ID: 22025782
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
[TBL] [Abstract][Full Text] [Related]
17. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
18. A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
Whitehouse F; Kruger DF; Fineman M; Shen L; Ruggles JA; Maggs DG; Weyer C; Kolterman OG
Diabetes Care; 2002 Apr; 25(4):724-30. PubMed ID: 11919132
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
